Eagle Global Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.5M Buy
+17,945
New +$18.3M 0.71% 36
2024
Q2
Sell
-599
Closed -$466K 243
2024
Q1
$466K Buy
599
+124
+26% +$88.2K 0.03% 180
2023
Q4
$277K Sell
475
-17
-3% -$9.92K 0.02% 203
2023
Q3
$264K Sell
492
-10
-2% -$5.15K 0.02% 198
2023
Q2
$235K Buy
+502
New +$211K 0.02% 207
2017
Q3
Sell
-3,012
Closed -$248K 312
2017
Q2
$248K Buy
+3,012
New +$246K 0.01% 329

Other funds holding LLY

Eagle Global Advisors's LLY Position: Q2 2026 in Review

Eagle Global Advisors opened a new position in Eli Lilly (LLY) in Q2 2026: 17,945 shares worth $21.5M. The stake represents 0.71% of the portfolio and ranks #36 among its holdings. This is a return to the name: Eagle Global Advisors previously reported a position in LLY as recently as Q1 2024.

Eagle Global Advisors first reported a position in LLY in Q2 2017 and has held it in 6 quarters since. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Eagle Global Advisors held 17,945 shares of Eli Lilly worth $21.5M as of Q2 2026.
  • Eli Lilly was a new Eagle Global Advisors position in Q2 2026.
  • Eli Lilly made up 0.71% of Eagle Global Advisors's portfolio in Q2 2026, its #36 holding.
  • Eagle Global Advisors first reported a position in Eli Lilly in Q2 2017 and has held it in 6 quarters since.
  • 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Eagle Global Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.